|1.||Foppen, Ewout: 1 article (08/2013)|
|2.||Fliers, Eric: 1 article (08/2013)|
|3.||Kalsbeek, Andries: 1 article (08/2013)|
|4.||Girault, Elodie M: 1 article (08/2013)|
|5.||Ackermans, Mariëtte T: 1 article (08/2013)|
|6.||Mela, Virginia: 1 article (03/2012)|
|7.||Marco, Eva M: 1 article (03/2012)|
|8.||Viveros, Maria-Paz: 1 article (03/2012)|
|9.||Borcel, Erika: 1 article (03/2012)|
|10.||Valero, Manuel: 1 article (03/2012)|
06/04/2004 - "These data show that an animal model of OLAN-induced weight gain is readily generated, and suggest that the weight gain results at least in part from increased food intake, reduced gross motor activity, and enhanced feed efficiency."
08/21/2013 - "Atypical antipsychotic drugs such as Olanzapine (Olan) induce weight gain and metabolic changes associated with the development of type 2 diabetes. "
|2.||Body Weight (Weight, Body)
03/01/2012 - "MD significantly diminished body weight gain, while Olan administration only induced a subtle decrease in body weight gain among female animals in the long-term. "
06/04/2004 - "Body weight returned to control levels once OLAN treatment was discontinued. "
06/04/2004 - "Rats receiving OLAN exhibited significant increases in body weight when compared with control rats. "
|3.||Substance Withdrawal Syndrome (Withdrawal Symptoms)
|1.||Antipsychotic Agents (Antipsychotics)